Stocktoria
COOPER COMPANIES, INC. COO
Nasdaq · XNAS · stock · Ophthalmic Goods · website · IPO 1983-01-21
COOPER COMPANIES, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% |
| Operating margin | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% |
| Net margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% |
| FCF margin | 10.6% | 7.4% | 6.0% | 13.6% | 17.9% |
| Return on assets | 3.0% | 3.2% | 2.5% | 3.4% | 30.7% |
| Return on equity | 4.6% | 4.9% | 3.9% | 5.4% | 42.4% |
| Debt / equity | 0.30× | 0.32× | 0.33× | 0.33× | 0.20× |
| Current ratio | 1.89 | 1.91 | 1.76 | 1.20 | 2.00 |
| Revenue growth | 5.1% | 8.4% | 8.6% | 13.2% | 20.2% |
Source: SEC EDGAR filings · CIK 0000711404 · as of 2025-10-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.